BioCryst Pharmaceuticals, Inc. (BCRX) is priced at $2.85 after the most recent trading session. At the very opening of the session, the stock started at $3.12 and reached a high price of $3.14, prior to closing the session the stock reached the value of $3.17. The stock touched a low price of $2.82.
BioCryst Pharmaceuticals, Inc. had a pretty Dodgy run when it comes to market performance. The 1-year high price for the company’s stock is recorded $9.95 on 01/28/19, with the lowest value was $1.38 for the same time period, on 11/14/19.
BioCryst Pharmaceuticals, Inc. (BCRX) full year performance was -67.65%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BioCryst Pharmaceuticals, Inc. shares are logging -71.36% during the 52-week period from to high price, and 106.52% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.38 and $9.95.
The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 3.03 million for the day, which was evidently higher when compared to average daily volumes of the shares.
When it comes to year-to-date metrics, the company recorded performance in the market by -17.39%, having the revenues showcasing 16.56% on a quarterly basis in comparison for the same period the last year. At the time of this writing, the total market value of the company is set at 458.42M, with the company having 100 employees.
The Analysts eye on BioCryst Pharmaceuticals, Inc.(BCRX)
According to the data provided on Barchart.com, the moving average for the company in the 100-day period was set at 2.71, with a change in the price noted at +0.17. In a similar fashion, BioCryst Pharmaceuticals, Inc. recorded a movement of +6.34% for the period of the last 100 days, recording 2,367,262 in trading volumes.
Technical Lookout on BioCryst Pharmaceuticals, Inc. (BCRX)
Raw Stochastic average of BioCryst Pharmaceuticals, Inc. in the period of last 50 days is set at 66.82%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 4.58%. In the last 20 days, the company’s Stochastic %K was 42.58% and its Stochastic %D was recorded at 59.25%.
Taking into consideration the past performance of BioCryst Pharmaceuticals, Inc., multiple moving trends are noted. Price performance for year-to-date for the company’s stock appears to be encouraging, given the fact the metric is recording -17.39%. Additionally, trading for the stock in the period of the last six months notably deteriorated to -20.83%, alongside a downfall of -67.65% for the period of the last 12 months. The shares increased approximately by 8.97% in the 7-day charts and went fell by -13.11% in the period of the last 30 days. Common stock shares were driven by 16.56% for the lastly recorded quarter.